Neogen Corporation Common Stock (NEOG)

About NEOG

Sector

Health Care

Industry

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Website

www.neogen.com/

Fundamentals

Market cap

$2.46B

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-0.04

Dividend yield

—

Beta

1.83

Avg. volume

—

Neogen Corporation Common Stock Competitors

Chosen by industry and closest market cap.

• NEOG

  Neogen Corporation Common Stock

  $11.67

  ▼ 0.60%
  Market cap $2.46BP/E —
  $4.9$12.85
• NTLA

  Intellia Therapeutics Inc. Common Stock

  $12.87

  ▼ 1.83%
  Market cap $1.57BP/E —
  $7.95$28.25
• NNNN

  Anbio Biotechnology Class A Ordinary Shares

  $7.64

  ▼ 1.80%
  Market cap $1.40BP/E 144.72
  $6.61$51.33
• ACHV

  Achieve Life Sciences Inc. Common Shares

  $8.09

  ▼ 1.16%
  Market cap $672.42MP/E —
  $2.62$8.61
• TKNO

  Alpha Teknova Inc. Common Stock

  $7.13

  ▼ 2.46%
  Market cap $350.10MP/E —
  $1.91$7.84
• IMDX

  Insight Molecular Diagnostics Inc. Common Stock

  $4.16

  ▼ 3.03%
  Market cap $154.99MP/E —
  $2.33$8.51
• QCLS

  Q/C Technologies Inc. Common Stock

  $2.37

  ▲ 0.00%
  Market cap $21.99MP/E —
  $2.3$8.94

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Piper Sandler Upgrades Neogen to Overweight, Raises Price Target to $14
  benzinga · 8/26/2026
• Piper Sandler Upgrades Neogen to Overweight, Raises Price Target to $14
  Benzinga · 8/26/2026
• The Bottom Fishing Club - Embecta: Excellent Turnaround Prospect In Defensive Medical Products
  SeekingAlpha · 8/24/2026
• SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICER
  Yahoo · 8/19/2026
• 3 Inflated Stocks Walking a Fine Line
  Yahoo · 8/19/2026
• 3 Unpopular Stocks with Questionable Fundamentals
  Yahoo · 8/18/2026
• Zoetis: A Solid Long-Term Buy After Harsh Drawdown
  SeekingAlpha · 8/18/2026
• Piper Sandler Reiterates Neutral on Neogen, Raises Price Target to $13
  Benzinga · 8/3/2026
• Neogen Corporation 2026 Q4 - Results - Earnings Call Presentation
  SeekingAlpha · 7/31/2026

• Nassif Mikheal · August 14, 2026 · Grant

  719.7K
• Nassif Mikheal · August 14, 2026 · Grant

  141.6K @ $11.65
• Moylan John Patrick · August 14, 2026 · Grant

  18.7K
• Moylan John Patrick · August 14, 2026 · Grant

  8.6K @ $11.65
• Ranalli Tamara A. · August 14, 2026 · Grant

  130.9K
• Ranalli Tamara A. · August 14, 2026 · Grant

  25.8K @ $11.65
• Riggsbee Richard Bryan · August 14, 2026 · Grant

  261.7K
• Riggsbee Richard Bryan · August 14, 2026 · Grant

  51.5K @ $11.65
• Stacey Jennifer Evans · August 14, 2026 · Grant

  196.3K
• Stacey Jennifer Evans · August 14, 2026 · Grant

  38.6K @ $11.65
• Nassif Mikheal · August 4, 2026 · Buy

  370 @ $11.81
• Moylan John Patrick · June 3, 2026 · Tax Withholding

  2.6K @ $8.75
• Rocklin Amy M · May 18, 2026 · Option Exercise

  35.2K @ $9.29
• Rocklin Amy M · May 18, 2026 · Tax Withholding

  10.2K @ $9.29
• Moylan John Patrick · May 4, 2026 · Option Exercise

  4.6K @ $9.53

Institutional Ownership

March 31, 2026

Total shares held

221.26M

Total value held

$1.87B

Institutional holders

303